Simultaneous diagnosis of plasma cell myeloma and chronic lymphocytic leukemia on bone marrow trephine biopsy Francesca MagnoliLorenzo CasicciaSilvia Uccella Images in Hematology 02 September 2022 Pages: 459 - 460
A rare case of multiple myeloma with Auer rod-like inclusions in plasma cells Kenta HayashinoMasayuki MatsudaToshi Imai Images in Hematology 03 September 2022 Pages: 461 - 462
VEXAS syndrome Kaori UchinoJo KanasugiAkiyoshi Takami Images in Hematology 03 September 2022 Pages: 463 - 464
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide Hirohisa Nakamae Review Article 05 August 2022 Pages: 465 - 481
Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia Daisuke MurakamiKensuke MatsudaMineo Kurokawa Original Article 24 June 2022 Pages: 482 - 488
Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R Ryui MiyashitaKeiko ShinozawaEi Kinai Original Article 19 May 2022 Pages: 489 - 499
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI) Yoshiaki TomiyamaStèphane ChezeRicardo Viana Original Article Open access 08 June 2022 Pages: 500 - 527
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation Sheng-Chieh ChouChing-Yeh LinMing-Ching Shen Original Article 08 June 2022 Pages: 528 - 533
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system Thao T. T. NguyenMinori TamaiTakeshi Inukai Original Article 06 May 2022 Pages: 534 - 543
Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease Megumi KoshiishiIchiro KawashimaKeita Kirito Original Article 10 May 2022 Pages: 544 - 552
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis Kihyun KimChang-Ki MinKenshi Suzuki Original Article 17 May 2022 Pages: 553 - 562
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma Satsuki MurakamiMasaki RiShinsuke Iida Original Article 14 June 2022 Pages: 563 - 569
Safety and efficacy of anagrelide in Japanese post-marketing surveillance, with subgroup analyses on the effect of previous cytoreductive therapies, age, and starting dose Norio KomatsuYoshinori HashimotoJovelle Fernandez Original Article Open access 27 May 2022 Pages: 570 - 578
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases Ami FukumotoToshiki TeraoKosei Matsue Original Article 10 July 2022 Pages: 579 - 585
Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges Saveria CapriaSilvia Maria TrisoliniMaurizio Martelli Original Article 13 May 2022 Pages: 586 - 593
Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation Takayoshi TachibanaMasatsugu TanakaHideaki Nakajima Original Article 09 May 2022 Pages: 594 - 602
Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography in relapsed and refractory aggressive lymphoma Takeshi SugioShingo BabaKoji Kato Original Article 14 June 2022 Pages: 603 - 611
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1) Hideki NakayamaChitose OgawaKeizo Horibe Original Article 30 May 2022 Pages: 612 - 621
Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report Yushi ChikasawaTakeshi HagiwaraEi Kinai Case Report 09 May 2022 Pages: 622 - 629
Successful HLA-haploidentical stem cell transplantation with post-transplant cyclophosphamide in an older patient with chronic active Epstein–Barr virus infection Masaya MaegakiKoji KawamuraTetsuya Fukuda Case Report 18 April 2022 Pages: 630 - 634
Familial hemophagocytic lymphohistiocytosis syndrome due to lysinuric protein intolerance: a patient with a novel compound heterozygous pathogenic variant in SLC7A7 Yukihiro MatsukawaKenichi SakamotoYoshihiro Maruo Case Report 09 May 2022 Pages: 635 - 638
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays Matthijs Vynck Letter to the Editor 16 September 2022 Pages: 639 - 640
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? Junji SuzumiyaJun Takizawa Correction 27 August 2022 Pages: 641 - 641
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study Yoko EdahiroKohshi OhishiKeita Kirito Correction 27 August 2022 Pages: 642 - 643